Capforce Inc. (CFOR) Stock Price & Analysis
Capforce Inc. (CFOR) rose 0.00% to USD 5.15 as of September 8, 2026 at 08:15 UTC, according to Nexqual real-time market data.
CFOR last closed at USD 5.15; the session ranged USD 5–5 on volume of 1 shares. Market capitalization is —, with a 52-week range of USD 0–34 (OQB). Source: Nexqual, September 8, 2026 at 08:15 UTC.
Key Statistics (as of September 8, 2026 at 08:15 UTC)
| Price | USD 5.15 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 5.15 |
| Open | USD 5.15 |
| Day Range | USD 5 – 5 |
| 52-Week Range | USD 0 – 34 |
| Volume | 1 shares |
| Market Cap | — |
| Exchange | OQB |
Technical Analysis (CFOR)
Nexqual's technical model rates CFOR "SELL" based on 1 bullish and 4 bearish signals across 129 daily candles, as of September 8, 2026 at 08:15 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 35.65 (neutral) |
| vs SMA50 | Below (USD 10.55) |
| MACD | -0.96 (negative) |
From Capforce Inc.'s Latest SEC 10-K Filing (filed 2026-05-26)
Key Strengths & Strategy (as disclosed to the SEC)
- This strategy leverages a combination of copyrights for our proprietary software code, user interface frameworks, and content; and trade secrets, including know-how, to safeguard our core algorithms, AI models, and confidential operational methodologies.
Partnerships
- In connection with the transactions contemplated by the March 2024 Purchase Agreement, the members of the Board of Directors, prior to the closing of such transactions, resigned, a new Board of Directors was appointed, of which Mr.
- With regard to public listing advisory services, CapForce must comply with any exchange-specific requirements.   Investment Advisory and Model-Enabled Advisory Regulation   The advanced computational model-enabled investment banking advisory platform to be offered by CapForce may be subject to investment advisory regulations in markets such as the U.S., Singapore, and Hong Kong.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AYTU | Aytu BioPharma, Inc. | USD 2.21 | ▼ 3.07% |
| PRPO | Precipio, Inc. | USD 27.4 | ▼ 0.36% |
| VTVT | vTv Therapeutics Inc. | USD 33.35 | ▼ 0.15% |
| AIM | AIM ImmunoTech Inc. | USD 0.23 | ▼ 1.04% |
| TENX | Tenax Therapeutics, Inc. | USD 1.94 | ▲ 4.86% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:15 UTC. This page is informational and not investment advice.